Skip to main content

Featured Stories

News
April 15, 2021
Alembic Pharmaceuticals Limited is recalling more than 12,000 bottles of telmisartan tablets after a bottle labelled to contain 20-mg tablets was found to contain 40-mg tablets.
Video
April 15, 2021
Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows…
Interview
April 15, 2021
Richard Miller, MD, board-certified oncologist and adjunct clinical professor of Medicine (oncology) at Stanford University Medical Center, discusses…
Commentary
April 14, 2021
When combining the high prevalence of hypertension with new aggressive treatment targets, a lot of patients may face the risk of having to take…
News
April 13, 2021
More women than men are getting COVID-19 vaccines, even as more men are dying of the disease. After examining vaccination dashboards for all 50…
News
April 07, 2021
Customer reports of product crystallization have prompted a Class I recall of acyclovir sodium injection.
Commentary
April 07, 2021
In this week’s issue of Talking Therapeutics, Dr Jennings examine the latest study surrounding the murky subject of anticoagulating patients with…
Commentary
April 06, 2021
Ken Cahill, CEO and co-founder of SilverCloud Health, explains why the solution to improving mental health treatment should involve scaling…
Video
April 05, 2021
Michael Ganio, PharmD, senior director of Pharmacy Practice and Quality, ASHP, breaks down the importance of centralized leadership and clear onsite…
Back to Top